By rray, 26 January, 2024 Ongoing monitoring required nbsp nbsp amiodarone TSH AST ALT q3 6mo ECG q1y CXR and physical exam for visual abnormalities skin changes neuro sx annually nbsp nbsp dofetilide ECG K Mg CrCl q3 6mo nbsp nbsp sotalol ECG K Mg CrCl q3 6mo
By rray, 26 January, 2024 Sotalol 2nd line option if no bradycardia Initiate as inpt for 3 day monitoring
By rray, 26 January, 2024 If no prolonged QT hypokalemia hypomagnesemia dofetilide is 1st line option w close monitor of QT K Mg and kidney function Initiate as inpt for 3 day monitoring
By rray, 26 January, 2024 If not candidate for ablation prescribe meds for long term maintenance of SR Consider medical hx and drug drug interactions for choice Options include
By rray, 26 January, 2024 If recurrent AF post ablation repeat ablation or initiate pharm options for rate or rhythm control
By rray, 26 January, 2024 Complications include LA esophageal fistula perforation w tamponade CVA TIA PV stenosis phrenic nerve paralysis vasc access complications death pneumonia
By rray, 26 January, 2024 1st line tx for paroxysmal AF in younger pts w few comorbidities to reduce progression to persistent AF Consider in others First line for paroxysmal AF or persistent AF w o major risk factors for recurrence 1